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ABSTRACT 
 
Background: Hyperglycemia is prevalent in critical care and tight control can save 
lives. Current ad-hoc clinical protocols require significant clinical effort and can often 
produce highly variable results. Thus, tight control remains elusive as there is not 
enough understanding of the relationship between control performance and protocol 
design – particularly with regard to how a given protocol is implemented. 
 
Methods: This paper examines the role of human factors and how individuals relate 
to technological protocols in clinical settings. The study consists of an overall brief 
review that is used to create a first graphical representation of the impact of human 
factors in clinical medical protocol implementations. This initial framework is 
examined in the context of two similar, but different, case studies – the SPRINT 
glycaemic control protocol and the TREAT system for antibiotic selection. 
 
Results: A graphical framework relating the human factors impact on medical 
protocol implementation is created. This framework describes the primary impacts on 
performance as resulting from clinical burden and protocol transparency. Their 
primary affect is on compliance with the protocol, which directly affects performance 
and outcome, particularly in long term studies versus short pilot studies. 
 
Summary: Compliance is a key element to obtaining the best clinical outcome that a 
given protocol can provide. The issues that most affect compliance are quite often 
unrelated to the patient or treatment, but are a function of the protocol design and its 
ability to integrate (by its design) into a given clinical setting. A framework for 
examining these issues in design and in post-hoc assessment is therefore proposed and 
examined in two brief case studies.  
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1.0 Introduction:  
 
Intensive insulin therapy (IIT) in the ICU has been of great interest since the landmark 
studies of van den Berghe et al [1, 2] and Krinsley [3]. The potential economic 
benefits of tight control have only served to increase the interest [4, 5]. Therefore, the 
idea that tight glycaemic control in critical care saves lives is increasingly less 
questioned. In contrast, the “how?” and “for whom?” remain elusive.  
 
To find these answers, increasingly more complex, often computerised and/or model-
based, protocols have been designed. Results are still often very variable due to 
differences in cohort, protocol, and potentially, compliance. In particular, recent 
studies [6, 7] have noted difficulties with compliance to timing or dosing, while others 
report excessive clinical burden associated with IIT [8-13].  
 
The performance or success of any clinical protocol will always depend primarily on 
its clinical efficacy. However, human factors must also be taken into consideration. A 
protocol may perform perfectly to clinical expectations and results with 100% 
compliance, but suffer much degraded performance if compliance is reduced, 
significantly influencing the clinical outcome and effectiveness. Thus, when a 
practitioner is faced with a clinical decision, the degree of decision support and how it 
is presented is an important factor for the decisions and actions they choose. 
 
Kawamoto et al [14], in a rigorous review of clinical decision support systems found 
four independent predictors of effective clinical decision support:  
 
1. Decision support provided automatically as part of clinician workflow 
2. Decision support provided at the time and place of decision making 
3. Actionable recommendations provided 
4. Computer based 
 
In this study, 94% of systems possessing all four features significantly improved 
clinical practice versus 46% for systems lacking one or more features. The results of 
Garg and Haynes et al [15, 16] found that automatically generated, versus user-
initiated, decision support resulted in better delivery. These findings suggest that 
effective clinical decision support systems must minimize the effort required by 
patients or caregivers to receive and act on recommendations, as well as pointing to 
compliance as a determining factor for clinical outcome. 
 
Overall, these results show that: 
 
1. Clinical burden is a major issue and can affect compliance and thus outcome 
2. Systems that reduce clinical effort can produce improved results 
3. Despite the improvements of computerisation, compliance and outcome are 
still variable in IIT and in general, and less than ideal. 
 
Hence, successful uptake of a protocol may well depend on non-physiological factors, 
relying instead on the ability to implement it effectively – the Human Factors. The 
goal of this paper is to introduce an initial, more formal problem definition to the 
field, rather than a specific solution. 
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2.0 Problem Definition: 
 
An overall assumption is that the full success of an effective IIT protocol is a function 
of compliance to that protocol’s requirements in timing and treatment. Thus, an 
effective IIT protocol that delivers tight control will provide strong objective feedback 
that bolsters compliance, while a poor one may not. However, several non-
physiological factors may also affect compliance or make it difficult to comply: 
 
1. Management and Collaboration: Relations between nursing staff, doctors, 
pharmacists and hospital management affects collaboration, especially if there 
is not a multi-disciplinary approach or lack of a clinical leader [17-20]. 
2. Clinical Burden: The time and effort to administer a protocol.  Complex 
protocols or those requiring many interruptions, trips from the bedside, 
extensive data management or input, or outside input directly affect 
compliance [17-19, 21-23]. These issues may all be enhanced by 
geographically distributed ICUs or blood glucose sensing, the time and effort 
required to maintain patient records in a given unit, and the level of critical 
illness of the patients [18, 19, 21, 22]. 
3. Transparency: Complex protocols, difficult interfaces, and frequent 
deviations or changes, serve to reduce consistency, remove insight into how 
the protocol works, and decrease trust in the protocol, all of which are 
important for good compliance to the guideline and reducing workarounds 
outside the protocol [17, 18, 21-24]. 
4. Training and Education: The level of training and education affects both the 
transparency and clinical effort required. Regular in-service training can also 
improve the efficiency of care and compliance to a protocol in longer term use 
[20, 25-29]. 
 
These four factors represent the specific human factors or issues that can affect 
compliance or/and performance. They may all map to one or more of the specific 
outcomes noted in the prior section resulting from the work of Kawamoto et al, or the 
final three points made with respect to IIT protocols. This paper proposes a 
framework in which addressing these issues will optimise the more general 
conclusions used to define the problem in the prior section. In particular, while 
clinical burden may be cited in many cases, these four factors more specifically target 
other aspects outside of that one issue or that may be conflated with it. 
 
Figure 1 shows a schematic of how these factors might interact to affect compliance 
and clinical outcome. The Human Factors box shows where human factors design 
could directly affect clinical outcome of a protocol. Finally, note that many of these 
same issues are also relevant to the compliance of individuals to prescribed or 
recommended therapies [26, 30-32]. 
 
[Insert Figure 1 here] 
 
From Figure 1 it can be seen that a human factors oriented design will not necessarily 
solve all problems. Certainly, training and education would be required in the 
implementation of any new protocol. Similarly, an atmosphere or organizational 
structure that makes collaboration between doctors, nurses, and other prescribing or 
purchasing authorities difficult will affect the ability to comply with a protocol, 
regardless of whether the protocol is otherwise well designed and effective.  
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Thus, the assumption is that where human factors design can play a role is in most 
effectively designing a protocol to match the clinical situation at the bedside. More 
specifically, it can help design the protocol to meet the workload, workflow, patient 
level and structural layout requirements of the specific ICU. In addition, its impact on 
interface design and ease of use will increase transparency of the protocol to the 
clinical end-users. 
 
 
3.0 Related Case Studies and Experiences: 
 
This section briefly examines the framework of Figure 1 in terms of a paper-based 
glycaemic control protocol developed from computerized versions, SPRINT [33-35], 
and a computerized decision support tool for antibiotic selection, TREAT [36, 37]. 
These examples are presented to show how any ICU decision support tool 
(computerized or not) might be analysed within this type of framework, rather than as 
representing any specific solution. Hence, these two systems represent to an extent, 
the extremes of media (paper for SPRINT and computer for TREAT) and complexity 
(a few calculations for SPRINT versus more extensive data entry and a Bayesian 
network for TREAT). 
 
3.1 TREAT:  
 
Appropriate antibiotic treatment decreases mortality and superfluous treatment is 
associated with antibiotic resistance. TREAT is a computerized decision support 
system for antibiotic treatment targeting these outcomes [36, 37]. In a multi-centre 
prospective and intervention cohort studies TREAT improved empirical antibiotic 
treatment selection prior to micro-biological diagnosis and reduced both cost and the 
superfluous use of broad spectrum antibiotics. In particular, length of hospital stay, 
costs associated with future resistance and total antibiotic costs were significantly 
reduced in the intervention groups. 
 
However, these positive results were not equivalent compared across the three 
different centers utilised in three different countries (Italy, Germany, and Israel). In 
particular, the first treatment recommended by TREAT in the intervention group was 
appropriate significantly more often (76%) than what was prescribed by physicians in 
the control group (65%). The actual rate of appropriate treatment achieved in the 
intervention group was 73% [36, 37], whereas the rate of appropriate treatment when 
TREAT’s advice was followed was 85% (per protocol analysis). Results were thus 
affected by incomplete acceptance and compliance with the systems 
recommendations.  
 
Factors that differed between clinical sites and presumably contributed to differences 
in compliance included a reported poor integration of the tool into the clinical 
workflow, as it was not made a regular part of their process. Thus, insufficient 
training of staff played a role directly and in terms of reported difficulty using a 
relatively complex, detailed and multi-level interface. It was a particular problem in 
some institutions during periods with high exchange rate of staff. Finally, this system 
could require as many as 20 different pieces of data entry to refine a solution 
(symptoms, test results, etc), so that a too high clinical burden was associated with 
data entry and thus, its use. Finally, there were also obvious differences between the 
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three clinical sites in terms of the support of the clinical trial from management, which 
then directly were reflected into the results.  
 
All of these factors can be found in the framework of Figure 1. Additionally, the long 
time lag between antibiotic selection and clinical outcomes reduces the positive effect 
from objective feedback, because these are only seen days or weeks later.  
 
The overall result was that in the intervention study the potential improvement of the 
clinical outcomes was not fully realised due to incomplete compliance.  
 
3.2 SPRINT:  
 
SPRINT is a paper-based tight glycaemic control system directly derived from a 
computerised protocol [33-35, 38, 39]. To date SPRINT has been utilised for 1.5 years 
and over 400 patients, delivering tight control and reduced mortality in the 
Christchurch Hospital ICU. While not a computerised protocol per se it offers added 
insight into the same human factors and design issues. 
 
Compliance with the protocol in dosing of insulin and nutritional inputs is over 93-5% 
for the first 384 patients and 42,000 interventions. Many of the existing errors are due 
primarily to small misinterpretations or use of the covered paper wheels that the 
system utilises, with the clinical staff choosing a value from an incorrect exposed 
column for example. Details on the SPRINT wheels and their ergonomics, design 
from computerised control methods, virtual trials, pilot testing and ongoing results are 
presented in several related works [34, 35, 40]. 
 
A primary reason for this level of compliance has been objective feedback with staff 
being able to see positive results relatively immediately in a clinical sense. 
Additionally, the protocol has remained unchanged and required no outside clinical 
intervention or deviation reducing both a measure of clinical burden and adding 
transparency. Transparency is also increased by the simplicity of the paper interface – 
nothing is hidden and what-if scenarios or other questions can easily be seen or 
answered. Another major factor may well be education and its continuing input. As 
clinical staff changes they are trained by experts, while every few months informal 
surveys collect feedback and provide answers to questions.  
 
Finally, the interface designed was created in consultation with ergonomics experts. 
The goal was to ensure that it was as easy to use as possible, and that mistakes would 
thus be minimised. This design was then taken to clinical nursing staff whose input on 
shape (wheels versus slides) coloring, size, and other metrics was also taken onboard 
in the design process. Note that this consultation also provided them a link and 
ownership of the protocol that might have ameliorated issues about management and 
ownership of the protocol and its use, although this specific aspect has not been 
surveyed.  
 
With regard to clinical burden, SPRINT requires no outside collaboration from 
bedside staff. It is well integrated into the clinical workflow because all measurements 
are taken at bedside where the wheels are located and used, rather than at a centralised 
blood gas analyser. The Christchurch Hospital also has an approximately 1:1 to 1:2 
nurse to patient ratio so the 1 or 2 hour intervention frequency (overall average 1.5 
hourly) is not outside of normal duties. Finally, in an early survey of clinical staff 
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users on the safety, efficacy and ease of use after the first ~30 total patients (1-2 per 
staff surveyed at ~1 month use), 95% of responses rated SPRINT as satisfactory or 
better, with 74% rating it good or very good [35]. These results show how designing 
the protocol in consultation with staff and in recognition of the local work practice 
can result in high compliance and end-user satisfaction, thus minimising any impact 
on the clinical outcome.  
 
 
4.0 Discussion: 
 
A common theme emerging from many studies is one of clinical burden or effort 
required, and its impact on the clinical results. The clinical burden of intensive insulin 
therapy (IIT) has not gone un-noticed [6-13, 41]. In particular, van den Berghe et al 
[2, 42] utilised extra nursing staff, while Krinsley [3] adjusted the protocol design to 
accommodate what might be accomplished with the staff available, and more recently 
Rea et al [25] utilised a dedicated pharmacist.  However, the idea that clinical effort 
can affect compliance to guidelines has only recently been discussed in the context of 
tight glycaemic control [6-8, 27, 43], although it is well reported in more generic ICU 
research [17-19]. 
 
Shulman and colleagues [6], addressed the issue of burden and compliance directly by 
computerising their protocol to reduce administration effort, and then tracking 
compliance in the timing of glucose measurements and thus perhaps compliance and 
performance in control. Only 53% of glucose measurements were performed in the 
specified 1-2 hour timeframe including a 50% (30-60 minutes) buffer. This result 
clearly shows the potential difficulty of integrating any protocol into the typically 
hectic ICU environment.  
 
Similarly, Rood et al [7] investigated the compliance differences between paper-based 
and computerised versions of the same protocol. In this study, timing compliance to a 
2 minute plus 5% buffer on 1-2 hourly measurements was 35% for paper-based and 
40% for computerised, indicating that, as reported elsewhere, computerised order 
systems can offer increased efficiency. Interestingly, Rood et al also investigated 
insulin dose compliance and found that there was also a difference (64% for paper-
based vs 77% for computerised) between protocols, which would have had a flow-on 
effect in terms of performance.  
 
The various degrees of compliance with TREAT recommendations compared to the 
SPRINT protocol may also be accounted for in at least two related ways. The two 
systems target different groups of health care personnel. TREAT gives 
recommendations to medical doctors, while SPRINT is executed by nurses. 
Willingness to comply with rigid clinical recommendations may be inversely 
correlated with the level of clinical training and skill, as well as the different demands 
for time and workflow on these two groups. In particular, more rigidly scheduled 
nursing staff monitoring a patient amidst other duties and interruptions [19] may be 
more willing to comply with recommendations and have less time to second guess 
them.  
 
TREAT and SPRINT also utilize different modes of knowledge representation. 
TREAT is computer based, while SPRINT was derived from a computerized protocol, 
but is implemented using cognitive artefacts - the paper based look up tables designed 
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as covered wheels to minimise user error and to increase the ease of use of the 
interface. Computer designs, by virtue, often abstract away implementation details, 
thereby removing cognitive load from practitioners. In contrast cognitive artefacts 
stimulate and support cognition in clinical work activities [44, 45]. For example the 
SPRINT wheels are used in an algorithm that involves cognitive processing of nursing 
staff at a number of decision points in the execution of the SPRINT protocol. A fully 
computerized protocol may remove this cognitive load, by taking control over each 
decision point and simply presenting an end action, but without explanation or 
intermediate steps that provide transparency. 
 
While removal of cognitive load from practitioners to computers may be experienced 
as a relief by some, it may also be counterproductive to compliance with system 
recommendations if these are perceived as the outcome of a magical black box, 
working in mysterious ways that are beyond the comprehension of even highly skilled 
clinicians. Thus, the designers of computer based medical decision support systems 
face the challenge of developing computer representations that balances the need for 
transparency, recognition, and making sense of processes underlying system 
recommendations, with the contrasting need to minimize clinical load. Specifically, 
balancing transparency and clinical burden in Figure 1 represents a potentially non-
trivial task for computerised decision support. 
 
With respect to the TREAT case study it is possible to hypothesize that the 
introduction of more effective objective feedback metrics would improve the 
compliance. Similarly, TREAT shows the difficulty that can be encountered if 
objective feedback is not available or difficult to supply with confidence, an issue that 
is less directly relevant to the glycaemic control case. More specifically, the response 
to glycaemic input is relatively rapid (30-90 minutes) and easily measured (blood 
glucose measurement). In contrast, the response to antibiotic therapy is not easily or 
directly measured and occurs potentially over several days. Hence, objective feedback 
is lost. In addition, there is less “immediacy”, which may also affect compliance and 
outcome, illustrating a fundamental difference potentially in designing protocols for 
insulin versus those for longer acting therapeutics like antibiotics. However, it is 
important to recollect that, per some of the results cited here, even immediate 
therapeutics like insulin can suffer from lack of compliance, so while a fast objective 
feedback may make the design easier, it does not necessarily free the protocol 
designer from having to consider these issues. 
 
It should not be taken that paper based protocols are better than computerised 
protocols given this difference in abstraction. Both may suffer from compliance or 
related issues in this framework. A more relevant conclusion would be that the design 
of a computer interface should better reflect the users it is intended for and their needs 
in terms of transparency and effort. It may therefore require more thought and effort 
in design, to which the field of human computer interaction (HCI) is devoted.  
 
Given the time periods for response computers may offer some advantages in certain 
instances. In particular, computerised glycemic control methods, like those of Wong 
et al [38], from which SPRINT was created, would not be feasible without a 
computational platform. However, glycemic control still typically provides 3-10 
minute windows for action, at a minimum, which are suitable for either type of 
protocol. Hence, there is no preference for any protocol in the media used, but rather 
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that how it is designed to be used best reflects the users needs and those issues 
outlined in the proposed framework.  
 
Finally, both TREAT and SPRINT were not integrated with computerised medical 
records. For TREAT this integration would save time on data entry for users [36], and 
thus reduce burden, while also providing, and gaining access to, more data to create 
objective feedback metrics. For a computerised form of SPRINT it can be 
hypothesized that this type of integration would potentially reduce clinical burden and 
provide greater transparency in the context of the patient’s ongoing care by providing 
immediate access to a wider range of data on patient condition and evolution. 
 
In terms of using the framework of Figure 1 or the elements within it, it is not possible 
to draw specific or quantitative conclusions. A great deal of work in the arena of 
interface design in general, has not yet led to such a result. In this sense it is better 
suited to guiding design and post-hoc assessment. A similar post-hoc approach 
followed by educational followup was used by Berenholtz and Pronovost et al [29] to 
improve ventilator therapy. In particular, the proposed framework would imply that 
not meeting any single criteria (e.g. education) would likely lead to a loss of 
performance. However, how much a loss would depend very much on several other 
factors including the clinical staff capability of those using it. Thus, one cannot use it 
to design for a certain level of acceptability or performance, where most likely better 
performance is related to meeting all of the criteria as much as may be possible.  
 
Speculatively, that last point may indicate that any protocol will require some measure 
of continuous update in education or assessment to ensure ongoing compliance and 
relevance. A specific limitation of this study is that it cannot conclusively or 
concretely state what does or does not make an interface more or less transparent, 
particularly for a computerised protocol. What is obvious to an experience user may 
be confusing to a less experienced person. Thus, each would require a different 
interface with different assumptions, similar to the prior discussion on the type of 
educational background of the user and their expectations. As a result, it might at least 
be concluded that such interfaces may well need to be designed to evolve with user 
preferences over time. 
 
 
Summary:  
 
Comparing SPRINT and TREAT, as well as other results in the area of computerised 
decision support in medicine, the same common themes emerge that are being seen by 
others in the field of glycemic control in critical care [6, 7, 27]. Specifically, that 
compliance is a key element to obtaining the best clinical outcome that a given 
protocol can provide. The issues that most affect compliance are quite often unrelated 
to the patient or treatment, but are a function of the protocol design and its ability to 
integrate into a given clinical setting.  
 
A framework for examining these issues in design is therefore proposed in Figure 1. It 
is designed as (at least) an opening statement in a discussion of how to better design 
protocols that are clinically and economically effective beyond well controlled pilot 
studies. As such its use would be intended for two phases: 1) design and guiding the 
development and testing of interfaces in particular; and 2) post-hoc assessment by 
guiding the surveying and objective data collected. 
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Finally, human factors and interface design are extremely broad research areas with a 
great deal of literature that cannot be summarised here. In addition, given the many 
variables of user, user education, geographical structure of the ICU, type of therapy 
being automated, and other factors described, any specific answers may well reside at 
the level of an individual protocol. However, the framework provided gives a 
foundation from which important questions can be asked in designing or 
implementing any protocol. Hence, the main result of this work may well be questions 
for analysis, rather than a conclusive recipe that overarches many or all glycemic 
control (or other) protocol implementations. 
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Figure 1: Graphical framework definition for the human factors aspects of tight protocol design as related to compliance and clinical outcome. 
Double lined boxes show main issues, and the single lined boxes selected relevant issues. 
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